Related Experiment Video
Updated: Oct 5, 2026

Gas Chromatography-Mass Spectrometry Paired with Total Vaporization Solid-Phase Microextraction as a Forensic Tool
Published on: May 25, 2021
Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies
1ULCA Department of Psychiatry and Biobehavioral Sciences, Los Angeles, California 90024, USA.
Abstract:
There is little medical information available about gamma-hydroxybutyrate (GHB) or gamma-butyrolactone (GBL) dependence or withdrawal. In this study the authors treated and reviewed multiple cases of GHB and GBL withdrawal in high-dose users. Five patients during nine hospitalizations were treated for GHB or GBL withdrawal. The authors describe a spectrum of GHB or GBL withdrawal from mild to severe and discuss medications used for treatment. They conclude that patients with GHB or GBL withdrawal may present with agitated psychosis, delirium, and autonomic instability. In this sample, relapse to GHB or GBL use occurred soon after treatment of withdrawal.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Hyperosmolar Hyperglycemic State
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines

